Serbia - serbio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

clinres farmacija d.o.o. beograd - karvedilol - tableta - 12.5mg

Serbia - serbio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

clinres farmacija d.o.o. beograd - karvedilol - tableta - 25mg

Serbia - serbio - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

clinres farmacija d.o.o. beograd - karvedilol - tableta - 6.25mg

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - carvedilolum - compresse - carvedilolum 12.5 mg, saccharum 12.5 mg, lactosum monohydricum 59.1 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, e 172 (flavum), e 172 (rubrum), pro compresso. - alfa e beta dei recettori adrenergici - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - carvedilolum - compresse - carvedilolum 25 mg, saccharum 25 mg, lactosum monohydricum 10 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, pro compresso. - alfa e beta dei recettori adrenergici - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - carvedilolum - compresse - carvedilolum 6.25 mg, saccharum 21.25 mg, lactosum monohydricum 51.8 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, e 172 (flavum), pro compresso. - alfa e beta dei recettori adrenergici - synthetika

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carvedilol 3.125mg;   - tablet - 3.125 mg - active: carvedilol 3.125mg   excipient: colloidal silicon dioxide crospovidone iron oxide red lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

Alemania - alemán - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

cheplapharm arzneimittel gmbh (8023489) - carvedilol - tablette - teil 1 - tablette; carvedilol (23059) 25 milligramm

Alemania - alemán - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

cheplapharm arzneimittel gmbh (8023489) - carvedilol - tablette - teil 1 - tablette; carvedilol (23059) 6,25 milligramm

Australia - inglés - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - carvedilol, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; magnesium stearate; colloidal anhydrous silica; povidone; crospovidone - dilatrend is indicated for the treatment for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to moderate (nyha class ii & iii) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ace inhibitors and vasodilators). indications as at 24 january 2002: dilatrend is indicated for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators). indications as at 3 march 2003: dilatrend is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).